Cognitive Task-Based Walking Effects on Cognition, Mood, Sleep, and Quality of Life in Older Adults With Brain Fog
The Effects of Cognitive Task-Based Walking Exercise on Cognitive Function, Depression, Sleep Quality, and Quality of Life in Older Adults With Brain Fog: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
This randomized controlled trial aims to investigate the effects of cognitive task-based walking exercise on cognitive function, depressive symptoms, sleep quality, and quality of life in older adults experiencing brain fog. Eligible participants will be randomly assigned to either a cognitive task-based walking exercise group or a walking-only exercise group. The intervention will be conducted under physiotherapist supervision, three times per week for four weeks. Outcome measures will be assessed at baseline and after the intervention period to compare the effectiveness of the two exercise approaches.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2026
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2026
CompletedApril 27, 2026
April 1, 2026
3 months
February 1, 2026
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Montreal Cognitive Assessment
Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), which evaluates multiple cognitive domains including attention, memory, executive functions, language, and orientation. Higher scores indicate better cognitive performance.
Baseline and after 4 weeks
Secondary Outcomes (4)
Brain Fog Scale
Baseline and after 4 weeks
Geriatric Depression Scale
Baseline and after 4 weeks
Pittsburgh Sleep Quality Index
Baseline and after 4 weeks
World Health Organization Quality of Life Instrument-Older Adults Module
Baseline and after 4 weeks
Study Arms (2)
Cognitive Task-Based Walking Exercise
EXPERIMENTALParticipants will perform low-intensity walking exercises combined with concurrent cognitive tasks under physiotherapist supervision, three times per week for four weeks.
Walking-Only Exercise
ACTIVE COMPARATORParticipants will perform the same low-intensity walking exercise protocol without cognitive tasks, under physiotherapist supervision, three times per week for four weeks.
Interventions
Participants will perform supervised low-intensity walking exercises combined with concurrent cognitive tasks targeting attention, memory, and executive functions, three times per week for four weeks. Each session will last 35 minutes, including a 5-minute warm-up, a 25-minute main walking phase, and a 5-minute cool-down.
Participants will perform supervised low-intensity walking exercises without concurrent cognitive tasks, three times per week for four weeks. Each session will last 35 minutes, including a 5-minute warm-up, a 25-minute main walking phase, and a 5-minute cool-down.
Eligibility Criteria
You may qualify if:
- Aged 65 years or older
- Self-reported experience of brain fog symptoms (e.g., reduced attention, concentration, or -mental clarity) for at least the past 4 weeks
- Moderate or higher brain fog severity as determined by the Turkish version of the Brain Fog Scale
- Preserved global cognitive function (Montreal Cognitive Assessment score ≥20)
- Ability to walk independently, with or without an assistive device
- Ability to communicate verbally and follow instructions
- No changes in medication and no acute illness within the past 4 weeks
- Willingness to participate and provide written informed consent
You may not qualify if:
- Diagnosed neurodegenerative or neurological disorders (e.g., Alzheimer's disease, stroke, or other major neurological conditions)
- Severe psychiatric disorders
- Medical contraindications to physical exercise
- Severe visual or hearing impairments interfering with assessment or exercise participation
- Inability to adhere to or complete the study procedures and exercise program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Emre Dansuk
Istanbul, Beykoz, 34815, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emre Dansuk, PhD
Medipol University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors will be independent from the intervention process and will be unaware of group assignments during baseline and post-intervention assessments.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
February 1, 2026
First Posted
February 9, 2026
Study Start
February 1, 2026
Primary Completion
April 22, 2026
Study Completion
April 22, 2026
Last Updated
April 27, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share